nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP1A2—chronic obstructive pulmonary disease	0.471	1	CbGaD
Ropivacaine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.045	0.15	CbGbCtD
Ropivacaine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0436	0.145	CbGbCtD
Ropivacaine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0436	0.145	CbGbCtD
Ropivacaine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0388	0.129	CbGbCtD
Ropivacaine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0366	0.122	CbGbCtD
Ropivacaine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0247	0.0821	CbGbCtD
Ropivacaine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0236	0.0783	CbGbCtD
Ropivacaine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.021	0.0698	CbGbCtD
Ropivacaine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0123	0.041	CbGbCtD
Ropivacaine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0116	0.0387	CbGbCtD
Ropivacaine—Levobupivacaine—CYP1A2—chronic obstructive pulmonary disease	0.00127	0.246	CrCbGaD
Ropivacaine—Lidocaine—EGFR—chronic obstructive pulmonary disease	0.00108	0.208	CrCbGaD
Ropivacaine—Bupivacaine—CYP1A2—chronic obstructive pulmonary disease	0.00101	0.196	CrCbGaD
Ropivacaine—Tocainide—CYP1A2—chronic obstructive pulmonary disease	0.000768	0.149	CrCbGaD
Ropivacaine—Lidocaine—CYP1A2—chronic obstructive pulmonary disease	0.000594	0.115	CrCbGaD
Ropivacaine—Tocainide—ALB—chronic obstructive pulmonary disease	0.000444	0.0859	CrCbGaD
Ropivacaine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.00136	CcSEcCtD
Ropivacaine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000281	0.00136	CcSEcCtD
Ropivacaine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.00136	CcSEcCtD
Ropivacaine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000281	0.00136	CcSEcCtD
Ropivacaine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.00136	CcSEcCtD
Ropivacaine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000281	0.00136	CcSEcCtD
Ropivacaine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00028	0.00136	CcSEcCtD
Ropivacaine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.00136	CcSEcCtD
Ropivacaine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00028	0.00136	CcSEcCtD
Ropivacaine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00136	CcSEcCtD
Ropivacaine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000279	0.00136	CcSEcCtD
Ropivacaine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000279	0.00136	CcSEcCtD
Ropivacaine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00136	CcSEcCtD
Ropivacaine—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000278	0.00135	CcSEcCtD
Ropivacaine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000277	0.00135	CcSEcCtD
Ropivacaine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.00135	CcSEcCtD
Ropivacaine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000275	0.00134	CcSEcCtD
Ropivacaine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000275	0.00134	CcSEcCtD
Ropivacaine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000274	0.00133	CcSEcCtD
Ropivacaine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.00133	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000272	0.00132	CcSEcCtD
Ropivacaine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00132	CcSEcCtD
Ropivacaine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00131	CcSEcCtD
Ropivacaine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00131	CcSEcCtD
Ropivacaine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00131	CcSEcCtD
Ropivacaine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000267	0.0013	CcSEcCtD
Ropivacaine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000267	0.0013	CcSEcCtD
Ropivacaine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00129	CcSEcCtD
Ropivacaine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00129	CcSEcCtD
Ropivacaine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00129	CcSEcCtD
Ropivacaine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000265	0.00129	CcSEcCtD
Ropivacaine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00128	CcSEcCtD
Ropivacaine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000263	0.00128	CcSEcCtD
Ropivacaine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000263	0.00128	CcSEcCtD
Ropivacaine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00128	CcSEcCtD
Ropivacaine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00128	CcSEcCtD
Ropivacaine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00127	CcSEcCtD
Ropivacaine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000262	0.00127	CcSEcCtD
Ropivacaine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00127	CcSEcCtD
Ropivacaine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00127	CcSEcCtD
Ropivacaine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00026	0.00127	CcSEcCtD
Ropivacaine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000258	0.00125	CcSEcCtD
Ropivacaine—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.00125	CcSEcCtD
Ropivacaine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000256	0.00124	CcSEcCtD
Ropivacaine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00123	CcSEcCtD
Ropivacaine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00123	CcSEcCtD
Ropivacaine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00122	CcSEcCtD
Ropivacaine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00122	CcSEcCtD
Ropivacaine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00025	0.00122	CcSEcCtD
Ropivacaine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00121	CcSEcCtD
Ropivacaine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000249	0.00121	CcSEcCtD
Ropivacaine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.0012	CcSEcCtD
Ropivacaine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.0012	CcSEcCtD
Ropivacaine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000245	0.00119	CcSEcCtD
Ropivacaine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00119	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000245	0.00119	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000245	0.00119	CcSEcCtD
Ropivacaine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00118	CcSEcCtD
Ropivacaine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00118	CcSEcCtD
Ropivacaine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000242	0.00118	CcSEcCtD
Ropivacaine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000241	0.00117	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00024	0.00117	CcSEcCtD
Ropivacaine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.00117	CcSEcCtD
Ropivacaine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00024	0.00117	CcSEcCtD
Ropivacaine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000239	0.00116	CcSEcCtD
Ropivacaine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000239	0.00116	CcSEcCtD
Ropivacaine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000238	0.00116	CcSEcCtD
Ropivacaine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00115	CcSEcCtD
Ropivacaine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000237	0.00115	CcSEcCtD
Ropivacaine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.00115	CcSEcCtD
Ropivacaine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000237	0.00115	CcSEcCtD
Ropivacaine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000236	0.00115	CcSEcCtD
Ropivacaine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000234	0.00114	CcSEcCtD
Ropivacaine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000234	0.00114	CcSEcCtD
Ropivacaine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000232	0.00113	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00112	CcSEcCtD
Ropivacaine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00023	0.00112	CcSEcCtD
Ropivacaine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00023	0.00112	CcSEcCtD
Ropivacaine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00023	0.00112	CcSEcCtD
Ropivacaine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00023	0.00112	CcSEcCtD
Ropivacaine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00112	CcSEcCtD
Ropivacaine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000229	0.00111	CcSEcCtD
Ropivacaine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00111	CcSEcCtD
Ropivacaine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.0011	CcSEcCtD
Ropivacaine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.0011	CcSEcCtD
Ropivacaine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000225	0.0011	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.00109	CcSEcCtD
Ropivacaine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000225	0.00109	CcSEcCtD
Ropivacaine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.00109	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.00109	CcSEcCtD
Ropivacaine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00109	CcSEcCtD
Ropivacaine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00109	CcSEcCtD
Ropivacaine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000223	0.00108	CcSEcCtD
Ropivacaine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000223	0.00108	CcSEcCtD
Ropivacaine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00108	CcSEcCtD
Ropivacaine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00108	CcSEcCtD
Ropivacaine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000221	0.00108	CcSEcCtD
Ropivacaine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00022	0.00107	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.00107	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00022	0.00107	CcSEcCtD
Ropivacaine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.00106	CcSEcCtD
Ropivacaine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.00106	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00105	CcSEcCtD
Ropivacaine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000215	0.00105	CcSEcCtD
Ropivacaine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00104	CcSEcCtD
Ropivacaine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00104	CcSEcCtD
Ropivacaine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000213	0.00103	CcSEcCtD
Ropivacaine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000213	0.00103	CcSEcCtD
Ropivacaine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000213	0.00103	CcSEcCtD
Ropivacaine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000213	0.00103	CcSEcCtD
Ropivacaine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000212	0.00103	CcSEcCtD
Ropivacaine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000212	0.00103	CcSEcCtD
Ropivacaine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00021	0.00102	CcSEcCtD
Ropivacaine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00021	0.00102	CcSEcCtD
Ropivacaine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00021	0.00102	CcSEcCtD
Ropivacaine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000209	0.00102	CcSEcCtD
Ropivacaine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00102	CcSEcCtD
Ropivacaine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000209	0.00101	CcSEcCtD
Ropivacaine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00101	CcSEcCtD
Ropivacaine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000208	0.00101	CcSEcCtD
Ropivacaine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000208	0.00101	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00101	CcSEcCtD
Ropivacaine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000205	0.000995	CcSEcCtD
Ropivacaine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000992	CcSEcCtD
Ropivacaine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.000981	CcSEcCtD
Ropivacaine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.000976	CcSEcCtD
Ropivacaine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.000976	CcSEcCtD
Ropivacaine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000198	0.000963	CcSEcCtD
Ropivacaine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.000963	CcSEcCtD
Ropivacaine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000198	0.000962	CcSEcCtD
Ropivacaine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000953	CcSEcCtD
Ropivacaine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000194	0.000943	CcSEcCtD
Ropivacaine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000193	0.000938	CcSEcCtD
Ropivacaine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.000938	CcSEcCtD
Ropivacaine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00019	0.000925	CcSEcCtD
Ropivacaine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00019	0.000925	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000923	CcSEcCtD
Ropivacaine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000189	0.000919	CcSEcCtD
Ropivacaine—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000911	CcSEcCtD
Ropivacaine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.000909	CcSEcCtD
Ropivacaine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000186	0.000906	CcSEcCtD
Ropivacaine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000184	0.000894	CcSEcCtD
Ropivacaine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.000894	CcSEcCtD
Ropivacaine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.00089	CcSEcCtD
Ropivacaine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.000886	CcSEcCtD
Ropivacaine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000881	CcSEcCtD
Ropivacaine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00018	0.000876	CcSEcCtD
Ropivacaine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.000873	CcSEcCtD
Ropivacaine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000178	0.000868	CcSEcCtD
Ropivacaine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000178	0.000865	CcSEcCtD
Ropivacaine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.000865	CcSEcCtD
Ropivacaine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000174	0.000847	CcSEcCtD
Ropivacaine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.000845	CcSEcCtD
Ropivacaine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.000831	CcSEcCtD
Ropivacaine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000171	0.000831	CcSEcCtD
Ropivacaine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.000824	CcSEcCtD
Ropivacaine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00017	0.000824	CcSEcCtD
Ropivacaine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000169	0.000824	CcSEcCtD
Ropivacaine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.000824	CcSEcCtD
Ropivacaine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000168	0.000819	CcSEcCtD
Ropivacaine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.000819	CcSEcCtD
Ropivacaine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.000818	CcSEcCtD
Ropivacaine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.000816	CcSEcCtD
Ropivacaine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000816	CcSEcCtD
Ropivacaine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000167	0.000814	CcSEcCtD
Ropivacaine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000166	0.000807	CcSEcCtD
Ropivacaine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000166	0.000807	CcSEcCtD
Ropivacaine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000805	CcSEcCtD
Ropivacaine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000804	CcSEcCtD
Ropivacaine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000165	0.000802	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000795	CcSEcCtD
Ropivacaine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.000793	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000791	CcSEcCtD
Ropivacaine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000791	CcSEcCtD
Ropivacaine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000785	CcSEcCtD
Ropivacaine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000782	CcSEcCtD
Ropivacaine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.000779	CcSEcCtD
Ropivacaine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000778	CcSEcCtD
Ropivacaine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.000778	CcSEcCtD
Ropivacaine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000778	CcSEcCtD
Ropivacaine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00016	0.000777	CcSEcCtD
Ropivacaine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.000777	CcSEcCtD
Ropivacaine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.000773	CcSEcCtD
Ropivacaine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.000762	CcSEcCtD
Ropivacaine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000156	0.000761	CcSEcCtD
Ropivacaine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.000752	CcSEcCtD
Ropivacaine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000749	CcSEcCtD
Ropivacaine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000737	CcSEcCtD
Ropivacaine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.000733	CcSEcCtD
Ropivacaine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00073	CcSEcCtD
Ropivacaine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000721	CcSEcCtD
Ropivacaine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.000708	CcSEcCtD
Ropivacaine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.000697	CcSEcCtD
Ropivacaine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000691	CcSEcCtD
Ropivacaine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.000684	CcSEcCtD
Ropivacaine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000647	CcSEcCtD
Ropivacaine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.00064	CcSEcCtD
Ropivacaine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.000636	CcSEcCtD
Ropivacaine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000634	CcSEcCtD
Ropivacaine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00063	CcSEcCtD
Ropivacaine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.000605	CcSEcCtD
Ropivacaine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000594	CcSEcCtD
Ropivacaine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000585	CcSEcCtD
Ropivacaine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000583	CcSEcCtD
Ropivacaine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000583	CcSEcCtD
Ropivacaine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000579	CcSEcCtD
Ropivacaine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000576	CcSEcCtD
Ropivacaine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000568	CcSEcCtD
Ropivacaine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000566	CcSEcCtD
Ropivacaine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000565	CcSEcCtD
Ropivacaine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000562	CcSEcCtD
Ropivacaine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000554	CcSEcCtD
Ropivacaine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000546	CcSEcCtD
Ropivacaine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000544	CcSEcCtD
Ropivacaine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000537	CcSEcCtD
Ropivacaine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000537	CcSEcCtD
Ropivacaine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000535	CcSEcCtD
Ropivacaine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00053	CcSEcCtD
Ropivacaine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000522	CcSEcCtD
Ropivacaine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000514	CcSEcCtD
Ropivacaine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000511	CcSEcCtD
Ropivacaine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000506	CcSEcCtD
Ropivacaine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000502	CcSEcCtD
Ropivacaine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000103	0.0005	CcSEcCtD
Ropivacaine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000497	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	9.64e-05	0.000469	CcSEcCtD
Ropivacaine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	9.63e-05	0.000468	CcSEcCtD
Ropivacaine—Insomnia—Prednisone—chronic obstructive pulmonary disease	9.57e-05	0.000465	CcSEcCtD
Ropivacaine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	9.5e-05	0.000462	CcSEcCtD
Ropivacaine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	9.32e-05	0.000453	CcSEcCtD
Ropivacaine—Rash—Prednisolone—chronic obstructive pulmonary disease	9.18e-05	0.000446	CcSEcCtD
Ropivacaine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	9.17e-05	0.000446	CcSEcCtD
Ropivacaine—Headache—Prednisolone—chronic obstructive pulmonary disease	9.12e-05	0.000444	CcSEcCtD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.07e-05	0.00521	CbGpPWpGaD
Ropivacaine—Constipation—Prednisone—chronic obstructive pulmonary disease	9.05e-05	0.00044	CcSEcCtD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	8.91e-05	0.00511	CbGpPWpGaD
Ropivacaine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	8.9e-05	0.00511	CbGpPWpGaD
Ropivacaine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.72e-05	0.000424	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	8.65e-05	0.000421	CcSEcCtD
Ropivacaine—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.65e-05	0.000421	CcSEcCtD
Ropivacaine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—chronic obstructive pulmonary disease	8.62e-05	0.00494	CbGpPWpGaD
Ropivacaine—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	8.57e-05	0.00491	CbGpPWpGaD
Ropivacaine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	8.56e-05	0.00491	CbGpPWpGaD
Ropivacaine—SCN9A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	8.43e-05	0.00484	CbGpPWpGaD
Ropivacaine—Urticaria—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.000409	CcSEcCtD
Ropivacaine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	8.37e-05	0.000407	CcSEcCtD
Ropivacaine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	8.37e-05	0.000407	CcSEcCtD
Ropivacaine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.13e-05	0.00467	CbGpPWpGaD
Ropivacaine—SCN3A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	8.07e-05	0.00463	CbGpPWpGaD
Ropivacaine—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.02e-05	0.0046	CbGpPWpGaD
Ropivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	8.01e-05	0.0046	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.96e-05	0.00456	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	7.89e-05	0.00453	CbGpPWpGaD
Ropivacaine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	7.8e-05	0.000379	CcSEcCtD
Ropivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.78e-05	0.00446	CbGpPWpGaD
Ropivacaine—SCN2A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	7.75e-05	0.00445	CbGpPWpGaD
Ropivacaine—SCN4A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	7.75e-05	0.00445	CbGpPWpGaD
Ropivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.68e-05	0.0044	CbGpPWpGaD
Ropivacaine—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.59e-05	0.000369	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	7.54e-05	0.00432	CbGpPWpGaD
Ropivacaine—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.49e-05	0.000364	CcSEcCtD
Ropivacaine—SCN1A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	7.47e-05	0.00429	CbGpPWpGaD
Ropivacaine—SCN10A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	7.47e-05	0.00429	CbGpPWpGaD
Ropivacaine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000352	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	7.21e-05	0.00414	CbGpPWpGaD
Ropivacaine—Dizziness—Prednisone—chronic obstructive pulmonary disease	7e-05	0.00034	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	6.93e-05	0.00397	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	6.93e-05	0.00397	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	6.74e-05	0.00387	CbGpPWpGaD
Ropivacaine—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.73e-05	0.000327	CcSEcCtD
Ropivacaine—SCN10A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	6.68e-05	0.00383	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	6.68e-05	0.00383	CbGpPWpGaD
Ropivacaine—Rash—Prednisone—chronic obstructive pulmonary disease	6.67e-05	0.000324	CcSEcCtD
Ropivacaine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.67e-05	0.000324	CcSEcCtD
Ropivacaine—Headache—Prednisone—chronic obstructive pulmonary disease	6.63e-05	0.000322	CcSEcCtD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.59e-05	0.00378	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.31e-05	0.00362	CbGpPWpGaD
Ropivacaine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	6.29e-05	0.00361	CbGpPWpGaD
Ropivacaine—Nausea—Prednisone—chronic obstructive pulmonary disease	6.29e-05	0.000306	CcSEcCtD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	5.92e-05	0.0034	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	5.92e-05	0.0034	CbGpPWpGaD
Ropivacaine—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	5.92e-05	0.0034	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	5.84e-05	0.00335	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.8e-05	0.00333	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—LEP—chronic obstructive pulmonary disease	5.79e-05	0.00332	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	5.77e-05	0.00331	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.73e-05	0.00329	CbGpPWpGaD
Ropivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.65e-05	0.00324	CbGpPWpGaD
Ropivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.58e-05	0.0032	CbGpPWpGaD
Ropivacaine—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	5.54e-05	0.00318	CbGpPWpGaD
Ropivacaine—SCN5A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	5.25e-05	0.00301	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	5.2e-05	0.00298	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	5.09e-05	0.00292	CbGpPWpGaD
Ropivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	5.02e-05	0.00288	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—MMP9—chronic obstructive pulmonary disease	4.88e-05	0.0028	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.87e-05	0.0028	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.82e-05	0.00277	CbGpPWpGaD
Ropivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.79e-05	0.00275	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.75e-05	0.00273	CbGpPWpGaD
Ropivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.73e-05	0.00271	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	4.7e-05	0.00269	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—LEP—chronic obstructive pulmonary disease	4.68e-05	0.00269	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.68e-05	0.00268	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.58e-05	0.00263	CbGpPWpGaD
Ropivacaine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	4.57e-05	0.00262	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—LEP—chronic obstructive pulmonary disease	4.48e-05	0.00257	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	4.38e-05	0.00251	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—LEP—chronic obstructive pulmonary disease	4.3e-05	0.00247	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—LEP—chronic obstructive pulmonary disease	4.3e-05	0.00247	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—LEP—chronic obstructive pulmonary disease	4.15e-05	0.00238	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—LEP—chronic obstructive pulmonary disease	4.15e-05	0.00238	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	4.12e-05	0.00237	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	4.05e-05	0.00232	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.03e-05	0.00231	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.02e-05	0.00231	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.98e-05	0.00229	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.96e-05	0.00227	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.96e-05	0.00227	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—MMP9—chronic obstructive pulmonary disease	3.94e-05	0.00226	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.94e-05	0.00226	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.88e-05	0.00223	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—MMP9—chronic obstructive pulmonary disease	3.77e-05	0.00216	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	3.72e-05	0.00213	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.7e-05	0.00212	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.69e-05	0.00212	CbGpPWpGaD
Ropivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3.65e-05	0.00209	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.64e-05	0.00209	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MMP9—chronic obstructive pulmonary disease	3.62e-05	0.00208	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—MMP9—chronic obstructive pulmonary disease	3.62e-05	0.00208	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.54e-05	0.00203	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.5e-05	0.00201	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MMP9—chronic obstructive pulmonary disease	3.49e-05	0.002	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—MMP9—chronic obstructive pulmonary disease	3.49e-05	0.002	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.48e-05	0.002	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.45e-05	0.00198	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.41e-05	0.00196	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.39e-05	0.00195	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.39e-05	0.00194	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.38e-05	0.00194	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.35e-05	0.00192	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.3e-05	0.0019	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	3.28e-05	0.00188	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.25e-05	0.00187	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.25e-05	0.00187	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.19e-05	0.00183	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.14e-05	0.0018	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.14e-05	0.0018	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.12e-05	0.00179	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.05e-05	0.00175	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—IL6—chronic obstructive pulmonary disease	3.03e-05	0.00174	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3e-05	0.00172	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—EGFR—chronic obstructive pulmonary disease	2.93e-05	0.00168	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—EGFR—chronic obstructive pulmonary disease	2.93e-05	0.00168	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—LEP—chronic obstructive pulmonary disease	2.92e-05	0.00167	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.87e-05	0.00165	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—EGFR—chronic obstructive pulmonary disease	2.82e-05	0.00162	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—EGFR—chronic obstructive pulmonary disease	2.82e-05	0.00162	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	2.82e-05	0.00162	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.81e-05	0.00161	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.81e-05	0.00161	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.79e-05	0.0016	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	2.77e-05	0.00159	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.76e-05	0.00158	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.74e-05	0.00157	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.69e-05	0.00154	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.68e-05	0.00154	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.64e-05	0.00151	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.6e-05	0.00149	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.59e-05	0.00148	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.59e-05	0.00148	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.57e-05	0.00147	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.55e-05	0.00146	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.53e-05	0.00145	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.53e-05	0.00145	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	2.5e-05	0.00143	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.5e-05	0.00143	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.49e-05	0.00143	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.49e-05	0.00143	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MMP9—chronic obstructive pulmonary disease	2.46e-05	0.00141	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—IL6—chronic obstructive pulmonary disease	2.45e-05	0.00141	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.43e-05	0.0014	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.42e-05	0.00139	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.4e-05	0.00138	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.4e-05	0.00138	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	2.38e-05	0.00136	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	2.38e-05	0.00136	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.37e-05	0.00136	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—IL6—chronic obstructive pulmonary disease	2.34e-05	0.00134	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.33e-05	0.00134	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.32e-05	0.00133	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.32e-05	0.00133	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.32e-05	0.00133	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.27e-05	0.0013	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—IL6—chronic obstructive pulmonary disease	2.25e-05	0.00129	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—IL6—chronic obstructive pulmonary disease	2.25e-05	0.00129	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.24e-05	0.00128	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.24e-05	0.00128	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.22e-05	0.00127	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	2.21e-05	0.00127	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.19e-05	0.00126	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.17e-05	0.00125	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.17e-05	0.00125	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—IL6—chronic obstructive pulmonary disease	2.17e-05	0.00125	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—IL6—chronic obstructive pulmonary disease	2.17e-05	0.00125	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.17e-05	0.00124	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.16e-05	0.00124	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.16e-05	0.00124	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.15e-05	0.00123	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.13e-05	0.00122	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.13e-05	0.00122	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.09e-05	0.0012	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.09e-05	0.0012	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.07e-05	0.00119	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.06e-05	0.00118	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.06e-05	0.00118	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.06e-05	0.00118	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.03e-05	0.00117	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.01e-05	0.00116	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.01e-05	0.00116	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.99e-05	0.00114	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.99e-05	0.00114	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—EGFR—chronic obstructive pulmonary disease	1.99e-05	0.00114	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.96e-05	0.00112	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.92e-05	0.0011	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.92e-05	0.0011	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.87e-05	0.00107	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.83e-05	0.00105	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	1.82e-05	0.00104	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.8e-05	0.00103	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.75e-05	0.00101	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.75e-05	0.001	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.69e-05	0.000968	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.68e-05	0.000963	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.67e-05	0.000959	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.66e-05	0.000952	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.66e-05	0.00095	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.61e-05	0.000921	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.61e-05	0.000921	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.59e-05	0.000913	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.57e-05	0.000903	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.57e-05	0.0009	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.55e-05	0.000888	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.55e-05	0.000888	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—IL6—chronic obstructive pulmonary disease	1.53e-05	0.000875	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.44e-05	0.000829	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.42e-05	0.000813	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.35e-05	0.000774	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.3e-05	0.000744	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.28e-05	0.000734	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.26e-05	0.000724	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.18e-05	0.000679	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.17e-05	0.000673	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.1e-05	0.00063	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.09e-05	0.000625	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.07e-05	0.000613	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.94e-06	0.00057	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.92e-06	0.000569	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.8e-06	0.000562	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.95e-06	0.000513	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.48e-06	0.000487	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	8.25e-06	0.000473	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.24e-06	0.000473	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.92e-06	0.000454	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.67e-06	0.00044	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.89e-06	0.000395	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.87e-06	0.000394	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	6.81e-06	0.000391	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.78e-06	0.000389	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.32e-06	0.000362	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.22e-06	0.000357	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.99e-06	0.000344	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.84e-06	0.000335	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.77e-06	0.000331	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.73e-06	0.000329	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.38e-06	0.000309	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.27e-06	0.000302	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.78e-06	0.000274	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.71e-06	0.00027	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.51e-06	0.000259	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.45e-06	0.000256	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.39e-06	0.000252	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.16e-06	0.000239	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	4.07e-06	0.000234	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.06e-06	0.000233	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.05e-06	0.000232	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.99e-06	0.000229	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.89e-06	0.000223	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.75e-06	0.000215	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.72e-06	0.000213	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.53e-06	0.000202	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.12e-06	0.000179	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.08e-06	0.000177	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.87e-06	0.000165	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.83e-06	0.000162	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.72e-06	0.000156	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.71e-06	0.000155	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.4e-06	0.000138	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.29e-06	0.000132	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.85e-06	0.000106	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.77e-06	0.000102	CbGpPWpGaD
